Compliance Certificate Clause 40(9)
We Are Enclosing Hereto The Compliance Certificate As Per Clause 40(9) In The Prescribed Format For The Quarter Ended 31St March, 2025
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Transgene Biotek Limited on 6ix
Earlier from Transgene Biotek
- Transgene Biotek Limited. Press Release Apr 19 2025
- Statement Of Deviation & Variation
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate: Annexure A
- Transgene Biotek Limited. Press Release Mar 29 2025
Later from Transgene Biotek
- Compliance-57 (5): intimation after the end of quarter
- Board Meeting Intimation for Intimation Of The Board Meeting Of The Company. This Is To Inform You That A Meeting Of Board Of Directors Of The Company Will Be Held On Wednesday 07Th May 2025.
- Transgene Biotek Limited. Press Release Apr 26 2025
- Board Meeting Outcome for Outcome Of Board Meeting And Submission Of Audited Financial Results For The Fourth Quarter And Financial Year Ended March 31, 2025
- Transgene Biotek Limited. Press Release May 07 2025
Follow Transgene Biotek into a list and get an email when it puts out news.
Follow Transgene Biotek